Atomistry » Fluorine » PDB 4q0e-4qrc » 4q1d
Atomistry »
  Fluorine »
    PDB 4q0e-4qrc »
      4q1d »

Fluorine in PDB 4q1d: Human Dck C4S-S74E Mutant in Complex with Udp and the Inhibitor 9 {2- {[(1R)-1-{2-[3-(2-Fluoroethoxy)-4-Methoxyphenyl]-5-Propyl-1,3- Thiazol-4-Yl}Ethyl]Sulfanyl}Pyrimidine-4,6-Diamine}

Enzymatic activity of Human Dck C4S-S74E Mutant in Complex with Udp and the Inhibitor 9 {2- {[(1R)-1-{2-[3-(2-Fluoroethoxy)-4-Methoxyphenyl]-5-Propyl-1,3- Thiazol-4-Yl}Ethyl]Sulfanyl}Pyrimidine-4,6-Diamine}

All present enzymatic activity of Human Dck C4S-S74E Mutant in Complex with Udp and the Inhibitor 9 {2- {[(1R)-1-{2-[3-(2-Fluoroethoxy)-4-Methoxyphenyl]-5-Propyl-1,3- Thiazol-4-Yl}Ethyl]Sulfanyl}Pyrimidine-4,6-Diamine}:
2.7.1.74;

Protein crystallography data

The structure of Human Dck C4S-S74E Mutant in Complex with Udp and the Inhibitor 9 {2- {[(1R)-1-{2-[3-(2-Fluoroethoxy)-4-Methoxyphenyl]-5-Propyl-1,3- Thiazol-4-Yl}Ethyl]Sulfanyl}Pyrimidine-4,6-Diamine}, PDB code: 4q1d was solved by J.Nomme, A.Lavie, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 27.39 / 2.00
Space group P 41
Cell size a, b, c (Å), α, β, γ (°) 68.734, 68.734, 120.623, 90.00, 90.00, 90.00
R / Rfree (%) 19.1 / 25.4

Fluorine Binding Sites:

The binding sites of Fluorine atom in the Human Dck C4S-S74E Mutant in Complex with Udp and the Inhibitor 9 {2- {[(1R)-1-{2-[3-(2-Fluoroethoxy)-4-Methoxyphenyl]-5-Propyl-1,3- Thiazol-4-Yl}Ethyl]Sulfanyl}Pyrimidine-4,6-Diamine} (pdb code 4q1d). This binding sites where shown within 5.0 Angstroms radius around Fluorine atom.
In total 2 binding sites of Fluorine where determined in the Human Dck C4S-S74E Mutant in Complex with Udp and the Inhibitor 9 {2- {[(1R)-1-{2-[3-(2-Fluoroethoxy)-4-Methoxyphenyl]-5-Propyl-1,3- Thiazol-4-Yl}Ethyl]Sulfanyl}Pyrimidine-4,6-Diamine}, PDB code: 4q1d:
Jump to Fluorine binding site number: 1; 2;

Fluorine binding site 1 out of 2 in 4q1d

Go back to Fluorine Binding Sites List in 4q1d
Fluorine binding site 1 out of 2 in the Human Dck C4S-S74E Mutant in Complex with Udp and the Inhibitor 9 {2- {[(1R)-1-{2-[3-(2-Fluoroethoxy)-4-Methoxyphenyl]-5-Propyl-1,3- Thiazol-4-Yl}Ethyl]Sulfanyl}Pyrimidine-4,6-Diamine}


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 1 of Human Dck C4S-S74E Mutant in Complex with Udp and the Inhibitor 9 {2- {[(1R)-1-{2-[3-(2-Fluoroethoxy)-4-Methoxyphenyl]-5-Propyl-1,3- Thiazol-4-Yl}Ethyl]Sulfanyl}Pyrimidine-4,6-Diamine} within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F301

b:66.8
occ:1.00
 FAF A:2Y1301 0.0 66.8 1.0
CAL A:2Y1301 1.4 67.9 1.0
CAM A:2Y1301 2.3 62.0 1.0
OG A:SER144 2.5 57.7 0.5
CB A:SER144 3.0 51.4 0.5
CB A:SER144 3.0 54.1 0.5
OG A:SER144 3.2 50.9 0.5
CE1 A:TYR204 3.3 65.4 1.0
OAS A:2Y1301 3.5 55.9 1.0
OD1 A:ASN140 3.8 42.0 1.0
CD2 A:LEU141 4.0 49.6 1.0
CD1 A:TYR204 4.1 64.6 1.0
O A:ASN140 4.2 46.9 1.0
OG A:SER146 4.2 45.8 1.0
CZ A:TYR204 4.3 63.7 1.0
OH A:TYR204 4.4 58.1 1.0
CA A:LEU141 4.5 44.9 1.0
CA A:SER144 4.5 49.1 0.5
CA A:SER144 4.5 50.4 0.5
CAZ A:2Y1301 4.6 62.0 1.0
CG A:ASN140 4.7 46.4 1.0
C A:ASN140 4.7 51.6 1.0
O A:SER144 4.9 48.2 1.0
N A:LEU141 4.9 49.0 1.0

Fluorine binding site 2 out of 2 in 4q1d

Go back to Fluorine Binding Sites List in 4q1d
Fluorine binding site 2 out of 2 in the Human Dck C4S-S74E Mutant in Complex with Udp and the Inhibitor 9 {2- {[(1R)-1-{2-[3-(2-Fluoroethoxy)-4-Methoxyphenyl]-5-Propyl-1,3- Thiazol-4-Yl}Ethyl]Sulfanyl}Pyrimidine-4,6-Diamine}


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 2 of Human Dck C4S-S74E Mutant in Complex with Udp and the Inhibitor 9 {2- {[(1R)-1-{2-[3-(2-Fluoroethoxy)-4-Methoxyphenyl]-5-Propyl-1,3- Thiazol-4-Yl}Ethyl]Sulfanyl}Pyrimidine-4,6-Diamine} within 5.0Å range:
probe atom residue distance (Å) B Occ
B:F301

b:60.6
occ:1.00
 FAF B:2Y1301 0.0 60.6 1.0
CAL B:2Y1301 1.3 57.6 1.0
OAS B:2Y1301 2.2 54.3 1.0
CAM B:2Y1301 2.2 55.7 1.0
CAZ B:2Y1301 3.6 54.6 1.0
OG B:SER144 3.6 47.0 0.5
CB B:SER144 3.8 48.6 0.5
CB B:SER144 3.9 43.8 0.5
OG B:SER144 3.9 39.0 0.5
CE1 B:TYR204 4.1 63.0 1.0
CD1 B:TYR204 4.3 56.3 1.0
CAJ B:2Y1301 4.3 56.6 1.0
OAR B:2Y1301 4.4 57.6 1.0
CAY B:2Y1301 4.5 54.6 1.0
OD1 B:ASN140 4.7 47.5 1.0
CD2 B:LEU141 4.8 44.5 1.0
CZ B:TYR204 4.9 63.5 1.0
OG B:SER146 4.9 44.4 1.0

Reference:

J.Nomme, Z.Li, R.M.Gipson, J.Wang, A.L.Armijo, T.Le, S.Poddar, T.Smith, B.D.Santarsiero, H.A.Nguyen, J.Czernin, A.N.Alexandrova, M.E.Jung, C.G.Radu, A.Lavie. Structure-Guided Development of Deoxycytidine Kinase Inhibitors with Nanomolar Affinity and Improved Metabolic Stability. J.Med.Chem. V. 57 9480 2014.
ISSN: ISSN 0022-2623
PubMed: 25341194
DOI: 10.1021/JM501124J
Page generated: Sun Dec 13 12:11:13 2020

Last articles

Zn in 8WB0
Zn in 8WAX
Zn in 8WAU
Zn in 8WAZ
Zn in 8WAY
Zn in 8WAV
Zn in 8WAW
Zn in 8WAT
Zn in 8W7M
Zn in 8WD3
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy